Defunct Company
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
74
NCT03351270
Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies
Phase: N/A
Role: Collaborator
Start: May 28, 2017
Completion: Sep 30, 2021
NCT04033159
Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 9, 2020
Completion: Jun 22, 2022
NCT04977648
Natural History Study of Patients With Centronuclear Myopathies
Start: Sep 30, 2022
Completion: Mar 31, 2026
NCT04743557
Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies
Start: Jan 31, 2024
Completion: Nov 30, 2025